Miao 2020.
Study characteristics | |||
Patient Sampling | 163 consecutive adult patients with suspected COVID‐19 from three tertiary hospitals in two provinces outside Hubei province | ||
Patient characteristics and setting | Setting: tertiary hospitals Site: 2 provinces outside Hubei province; fever emergency clinics at Shanghai General Hospital, High‐tech hospital (First Affiliated Hospital of Nanchang University) and People's hospital of Yinchun City from 12 January‐13 February 2020 Country: China Symptoms and severity: suspected of COVID‐19 visiting fever emergency clinics; the most common symptoms on admission were fever (49 (79.0%)), dry cough (37 (59.7%)), fatigue or myalgia (15 (24.2%)) Demographics: 62 cases confirmed and 102 cases unconfirmed. Mean age confirmed group: 43.8 (SD 13.9; range 19‐77); mean age unconfirmed group: 41.3 (SD 14.7; range 19‐81); confirmed group 32 (51.6%) men and non confirmed group 68 (67.3%) men Time since onset of symptoms was 7.0 (3.5‐9.0) days (confirmed group) and 6.0 (4.0‐9.0) days (unconfirmed group). Compared with participants in unconfirmed group, participants in confirmed group had significantly higher proportion of Wuhan residence history, having visited Wuhan, clustering diseases and dry cough |
||
Index tests | WBC count, PCT, ALT, LDH, creatinine kinase, troponin I. Table 4 | ||
Target condition and reference standard(s) | RT‐PCR. sample: nasopharyngeal swabs or sputum specimens; the confirmed group was defined as a positive result of at least 1 RT‐PCR test for SARS‐CoV‐2. The unconfirmed group was defined as all results of RT‐PCR tests were negative | ||
Flow and timing | Time interval not reported; all participants received the same reference standard; no missing data or uninterpretable results | ||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Could the selection of patients have introduced bias? | Low risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Unclear | ||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |